Real-time enrollment status for this diffuse large b-cell lymphoma clinical trial
Current Status
Recruiting
Checked: July 13, 2026 at 6:36 AM UTC
| NCT Number | NCT05512390 |
| Recruiting Status | Recruiting |
| Condition | Diffuse Large B-Cell Lymphoma |
| Phase | Clinical Trial |
| Target Enrollment | 154 participants |
| Active Locations | 8 sites in the US |
| Sponsor | AbbVie |
| Last Updated on CT.gov | January 16, 2026 (Jan 16, 2026) |
As of July 13, 2026: Clinical trial NCT05512390 is currently recruiting participants. This clinical trial study for diffuse large b-cell lymphoma is actively seeking new participants at 8 locations across the United States. The study is sponsored by AbbVie. This status information is automatically verified from the official ClinicalTrials.gov registry.
Yes, NCT05512390 is actively recruiting participants as of July 13, 2026. You can check eligibility and apply through HelloStudys.
This trial is recruiting at 8 locations in the United States. View all available locations on the full study page.
Check your eligibility and express interest by completing the application form on the study page. A research coordinator will follow up to discuss next steps.
The official ClinicalTrials.gov record for NCT05512390 was last updated Jan 16, 2026 (January 16, 2026). HelloStudys verifies this status automatically.